PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30951845-10	2019	Moreover, we found that Cs-ME reduced the phosphorylation of NF-kappaB upstream signaling molecules including IkappaBalpha, IKKalpha/beta, Src, and Syk in LPS-stimulated macrophage-like RAW264.7 cells.	cs-me	24-29	Rous sarcoma oncogene	Mus musculus	139-142	
30951845-11	2019	The results of Western blot and CETSA confirmed that Src and Syk are anti-inflammatory targets of Cs-ME.	cs-me	98-103	Rous sarcoma oncogene	Mus musculus	53-56	
30951845-14	2019	CONCLUSIONS: Cs-ME exhibits anti-inflammatory effects in vitro and in vivo by targeting Src and Syk in the NF-kappaB signaling pathway.	cs-me	13-18	Rous sarcoma oncogene	Mus musculus	88-91